MabVax Therapeutics Holdings (MBVX) Starts Presentation at LD Micro Main Event
MabVax Therapeutics Holdings (NASDAQ: MBVX) is a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of proprietary human monoclonal antibody products and vaccines for the diagnosis and treatment of various cancers. MabVax Therapeutics has a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers. For more information, visit the company's website at www.mabvax.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive…







